TRI-NORINYL SUMMARY
WATSONPHARMA
IN-5220/S
PHYSICIAN LABELING
Tri-Norinyl ®
(Norethindrone and Ethinyl Estradiol Tablets USP)
Rx only
Tri-Norinyl ® provides a continuous oral contraceptive regimen of 7 blue tablets, 9 yellow-green tablets, 5 more blue tablets, and then 7 orange tablets. Each blue tablet contains norethindrone 0.5 mg and ethinyl estradiol 0.035 mg, each yellow-green tablet contains norethindrone 1 mg and ethinyl estradiol 0.035 mg, and each orange tablet contains inert ingredients. Norethindrone is a potent progestational agent with the chemical name 17-Hydroxy-19-nor-17α-pregn-4-en-20-yn-3-one. Ethinyl estradiol is an estrogen with the chemical name 19-Nor-17α-pregna-1,3,5 (10)-trien-20-yne-3,17-diol.
Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.
Oral contraceptive products such as Norinyl, which contain 50 mcg of estrogen, should not be used unless medically indicated.
|
TRI-NORINYL NEWS HIGHLIGHTS
Media Articles Related to Tri-Norinyl (Norethindrone / Estradiol / Norethindrone / Estradiol)
Leavitt's Actions On HHS Draft Rule Leave Possibility That It Will Be Used To Refuse Contraception, Opinion Piece Says
Source: Sexual Health / STDs News From Medical News Today [2008.09.03]
Governor Palin Is Pro-Life, Pro-contraception, And Pro-competition In Health Care
Source: Abortion News From Medical News Today [2008.08.30]
New Concepts In Contraception
Source: Sexual Health / STDs News From Medical News Today [2008.08.28]
'Extended Cycle' Contraception Garners More Interest
Source: MedicineNet Birth Control Specialty [2008.08.25]
Male Contraception: Progress Slow but Steady
Source: MedicineNet Vasectomy Specialty [2008.04.14]
Published Studies Related to Tri-Norinyl (Norethindrone / Estradiol / Norethindrone / Estradiol)
Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study. [2007.09]
Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO. [2003.07]
Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20. [2001.06]
Comparative clinical evaluation of the effect on carbohydrate and lipid metabolism of two norethisterone-containing hormonal contraceptives: Mesigyna and TriNovum. [1997.05]
A triphasic oral contraceptive pill, CTR-05: clinical efficacy and safety. [1996.09]
Clinical Trials Related to Tri-Norinyl (Norethindrone / Estradiol / Norethindrone / Estradiol)
Study of Loestrin 24(24 Days of "Real" Pills) Fe Versus Loestrin 1/20 (21 "Real" Pills) [Active, not recruiting]
Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS Women [Not yet recruiting]
Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women [Active, not recruiting]
A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers [Active, not recruiting]
Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study [Active, not recruiting]
|
